官方服务：
资源简介：
Complications during VL treatment.
应用场景：
创建时间：
2020-01-24
相关数据集
Demographic and clinical characteristics of visceral leishmaniasis and HIV co-infected patients treated with a combination of liposomal amphotericin B (AmBisome) and miltefosine by MSF in Ethiopia from January 2011 to August 2014, by visceral leishmaniasis treatment history.
Demographic and clinical characteristics of visceral leishmaniasis and HIV co-infected patients treated with a combination of liposomal amphotericin B (AmBisome) and miltefosine by MSF in Ethiopia fro
NIAID Data Ecosystem30
Overall complications.
*p-value is provided between the group without urological complications and the group with urological complications.PCN: Percutaneous Nephrostomy; ATN: Acute Tubulus Necrosis.
Figshare2015-12-02 更新20
Supplementary Material for: Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study
Introduction: Regional citrate anticoagulation (RCA) is the recommended anticoagulation modality for continuous renal replacement therapy (CRRT). RCA was associated with a low rate of complications in
Figshare2020-03-03 更新70
MOESM1 of Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
Additional file 1. Anonymous patient data. The dataset supporting the conclusions of this article.
NIAID Data Ecosystem20
